SS Innovations International (SSII) Return on Capital Employed (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999.00 |
| Dec 31, 2025 | 1,608.00 |
| Sep 30, 2025 | 440.00 |
| Jun 30, 2025 | 2,360.00 |
| Mar 31, 2025 | 9,236.00 |
| Dec 31, 2024 | -1,227.00 |
| Sep 30, 2024 | -1,886.00 |
| Jun 30, 2024 | 624.00 |
| Mar 31, 2024 | -4,794.00 |
| Dec 31, 2023 | -1,866.00 |
| Sep 30, 2023 | 75,080.00 |
| Jun 30, 2023 | -54,655.00 |
| Mar 31, 2023 | -34,157.00 |
| Dec 31, 2022 | -38,889.00 |
| Sep 30, 2022 | 199,978.00 |
| Jun 30, 2022 | -49,373.00 |
| Mar 31, 2022 | 51,923.00 |
| Dec 31, 2021 | -172,749.00 |
| Sep 30, 2021 | -284.00 |
| Jun 30, 2021 | 2,107.00 |
| Mar 31, 2021 | 2,183.00 |
| Dec 31, 2020 | -3,683.00 |
| Sep 30, 2020 | -9,957.00 |
| Jun 30, 2020 | -5,933.00 |
| Mar 31, 2020 | -1,720.00 |
| Dec 31, 2019 | 3,395.00 |
| Sep 30, 2019 | 8,432.00 |
| Jun 30, 2019 | -3,170.00 |
| Mar 31, 2019 | -27,355.00 |
| Dec 31, 2018 | -1,623.00 |
| Sep 30, 2018 | 424,328.00 |
| Jun 30, 2018 | -322,037.00 |
| Mar 31, 2018 | 27,718.00 |
| Dec 31, 2017 | -38,063.00 |